NIH-funded research R01 grant

Identifying biomarkers related to memory issues in temporal lobe epilepsy

Official title: Molecular Profiling and Biomarkers of Memory Phenotypes in Temporal Lobe Epilepsy

Funded at Cleveland Clinic Lerner Com-Cwru · NIH-10979812 · Data updated 2026-11-12

This study is looking at how memory problems in adults with tough-to-treat temporal lobe epilepsy might be linked to changes in their genes and proteins, so we can find better ways to help those who struggle with memory, even if they seem okay on the surface.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCleveland Clinic Lerner Com-Cwru
NIH-funded
Lab location1 site (Cleveland, United States)
Project startJuly 15, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$577,978
NIH project number1R01NS135080-01A1
Project IDNIH-10979812 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults diagnosed with temporal lobe epilepsy, particularly those with pharmacoresistant mesial TLE and hippocampal sclerosis.

Less likely to help

Patients with temporal lobe epilepsy who do not experience memory deficits or have other unrelated neurological conditions may not benefit from this research.

What this research studies

This research focuses on understanding the memory deficits associated with temporal lobe epilepsy (TLE), particularly in adults who have pharmacoresistant mesial TLE and hippocampal sclerosis. The study aims to identify molecular biomarkers that can predict memory impairment, even in patients who appear to have intact memory despite significant brain damage. By analyzing blood samples and brain tissue, researchers will explore the genetic and protein expressions linked to memory function. The ultimate goal is to develop personalized prognostic models that can inform treatment strategies for those affected by memory dysfunction due to TLE.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic tools and targeted therapies for patients with memory impairments related to temporal lobe epilepsy.

How similar studies have gone: Previous research has shown promise in identifying biomarkers for neurological conditions, suggesting that this approach could yield valuable insights, although the specific focus on TLE and memory dysfunction is relatively novel.

Where this research is happening

  • Cleveland Clinic Lerner Com-Cwru
    Cleveland, United States
    Active

Researchers

  • Principal investigator: Busch, Robyn M — Cleveland Clinic Lerner Com-Cwru
  • Study coordinator: Busch, Robyn M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.